Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

997 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The frequency of violence against women, or intimate partner violence (IPV) is more and more underlined and recognized as a cofactor favoring certain somatic and psychic pathologies. However, its incidence in patients with venous thromboembolism (VTE) is unknown and its status as a risk factor is still elusive and ambiguous.

Investigators therefore conducted a matched case-control study consisting of women taking combined oral contraceptives (COC) who were investigated and followed up between 2010 and 2020.

The cases are the patients investigated for their first venous thromboembolic event, The controls were women free of thrombosis who had regular gynecological checkups. Case-control pairs were matched on region of residence, age (+/- 2 years), duration of COC intake (+/- 4 months), COC type (2nd, 3rd or 4th generation).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations

NCT06415968

Intimate Partner Violence Deep Vein Thrombosis (DVT)/Thrombophlebitis Pulmonary Embolism and Thrombosis

TERMINATED

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure

NCT03206372

Venous Thromboembolic Disease

RECRUITING

Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic Episode

NCT04920487

Venous Thromboembolism

COMPLETED

Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women

NCT00745212

Placental Vascular Pathologies Venous Thromboembolism Diseases

COMPLETED

Medical Assistance for the Procreation and Risk of Thrombosis.

NCT02610608

Ovarian Hyperstimulation Syndrome Cardiovascular Diseases Embolism and Thrombosis

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

First venous thromboembolic event associated with combined oral contraceptives intake

WAST questionnaire

Intervention Type OTHER

WAST questionnaire, designed and validated as a screening tool for violence against women and intimate partner violence.

(ref: Brown JB, Lent B, Brett PJ, Sas G, Pederson LL. Development of the Woman Abuse Screening Tool for use in family practice. Fam Med. 1996 Jun;28(6):422-8.)

Controls

regular follow-up of their combined oral contraception

WAST questionnaire

Intervention Type OTHER

WAST questionnaire, designed and validated as a screening tool for violence against women and intimate partner violence.

(ref: Brown JB, Lent B, Brett PJ, Sas G, Pederson LL. Development of the Woman Abuse Screening Tool for use in family practice. Fam Med. 1996 Jun;28(6):422-8.)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

WAST questionnaire

WAST questionnaire, designed and validated as a screening tool for violence against women and intimate partner violence.

(ref: Brown JB, Lent B, Brett PJ, Sas G, Pederson LL. Development of the Woman Abuse Screening Tool for use in family practice. Fam Med. 1996 Jun;28(6):422-8.)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients: first venous thromboembolic event associated with the intake of combined oral contraceptives
* Controls: regular follow-up of their combined oral contraception
* Patient-Control pairs matched on region of residence, age, duration of COC intake, type of COC.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes